title: IL-1 blockade in Schnitzler syndrome: ex vivo findings correlate with clinical remission.
authors.forename: John G
authors.initials: JG
authors.lastname: Ryan
authors.forename: Heleen D
authors.initials: HD
authors.lastname: de Koning
authors.forename: Lisa A
authors.initials: LA
authors.lastname: Beck
authors.forename: Matthew G
authors.initials: MG
authors.lastname: Booty
authors.forename: Daniel L
authors.initials: DL
authors.lastname: Kastner
authors.forename: Anna
authors.initials: A
authors.lastname: Simon
mesh_terms: D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein / Q000008:administration & dosage / Q000627:therapeutic use*; D007375:Interleukin-1 / Q000037:antagonists & inhibitors*; D008875:Middle Aged; D019873:Schnitzler Syndrome / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D018501:Antirheumatic Agents; D053590:Interleukin 1 Receptor Antagonist Protein; D007375:Interleukin-1